drugset / Trial / NCT03353506
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Fecal microbiota transplantation (FMT) for the treatment of recurrent Clostridium difficile infection (RCDI) has traditionally been offered as fecal slurry administered by enema, nasogastric tube or endoscopy. Frozen oral capsules have also shown efficacy. The potential advantage of lyophilized FMT is the relative ease of manufacturing and storage compared with fecal slurry. Sterile fecal filtrate has previously been shown to prevent Clostridium difficile infection (CDI) recurrence, suggesting that live bacteria may not be needed. This study will compare lyophilized sterile fecal filtrate (LSFF) with lyophilized FMT (LFMT) in the treatment of recurrent Clostridium difficile infection (RCDI).
Timeline
- Start
- 2018-02-14
- Primary completion
- 2019-06-05
- Completion
- 2019-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lyophilized fecal microbiota transplant | Other / unclassified | 15 unknown | Oral |
| Subject | Lyophilized sterile fecal filtrate | Other / unclassified | 15 unknown | Oral |